Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-14 Sale | 2021-12-16 9:30 pm | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 355,705 | $67 | $23,833,381 | 185,686 (Indirect) | View |
| 2021-11-10 Sale | 2021-11-15 9:45 pm | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 134,310 | $85.83 | $11,527,510 | 541,391 (Indirect) | View |
| 2021-11-05 Sale | 2021-11-09 9:47 pm | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 172,079 | $93.02 | $16,006,424 | 675,701 (Indirect Direct) | View |
| 2020-12-18 Purchase | 2020-12-21 6:00 pm | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 142,857 | $70 | $9,999,990 | 822,857 (Indirect) | View |
| 2020-03-03 Purchase(A) | 2020-03-13 5:20 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 552,800 | $18 | $9,950,400 | 2,619,430 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:48 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,800 | $18 | $50,400 | 2,800 (Direct) | View |
| 2019-11-12 Purchase | 2019-11-14 4:23 pm | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 680,000 | $22 | $14,960,000 | 680,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-09 Option Award | 2023-06-09 6:20 pm | N/A 2033-06-08 | Disc Medicine Inc. | IRON | Ratcliffe Liam Director | 7,136 | $0 | 7,136 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:11 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-12-29 Option Award | 2023-01-03 5:05 pm | N/A 2032-12-28 | Disc Medicine Inc. | IRON | Ratcliffe Liam Director | 7,000 | $0 | 7,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 8:00 pm | N/A 2032-06-15 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 10,192 | $0 | 10,192 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:14 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A 2029-05-22 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 18,423 | $0 | 675,701 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A N/A | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 6,423 | $22.06 | 675,701 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A N/A | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 12,000 | $33.57 | 675,701 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:23 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-08-09 6:22 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 0 | $0 | 0 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 8:00 pm | N/A 2021-06-07 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 7,511 | $0 | 7,511 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:58 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-04 9:00 pm | N/A 2030-06-02 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A 2029-05-22 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 6,500 | $0 | 692,923 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A N/A | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 6,500 | $22.06 | 692,923 (Direct) | View |
| 2020-03-03 Conversion(A) | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,619,430 (Indirect) | View |
Ownership(A) | 2020-03-12 7:02 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 0 | $0 | 2,066,630 (Indirect) | View |
| 2020-02-27 Option Award | 2020-03-02 5:58 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:27 pm | N/A 2029-06-14 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 7,881 | $1.6654 | 7,881 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 5:11 pm | N/A 2029-05-22 | ARVINAS INC. | ARVN | Ratcliffe Liam Director | 12,923 | $0 | 12,923 (Direct) | View |